Amazon’s yearslong foray into health care still hasn’t upended the industry, and it’s unclear if the recent steps will change that pattern.
Experts told lawmakers in a hearing last week that adding geographic diversity and careful planning could strengthen the health care supply chain.
Logistics is the name of the game when it comes to getting health care supplies to patients in disaster zones or places experiencing disease outbreaks.
Companies in the health care supply chain are preparing to change gears as COVID-19 cases fall and health care utilization returns to normal levels.
Health care distributors ramped up distribution of PPE and vaccines during the pandemic but normal health care usage fell.
Drug manufacturers say contingency plans have helped avoid major disruptions to production, but hospitals still face shortages.
How would intellectual property waivers affect the vaccine supply chain? Supporters say sharing IP will boost production. Others say a lack of workers, production facilities and supplies means sharing IP won’t help.
As the number of COVID-19 cases decreases, some manufacturers and suppliers of personal protective equipment are predicting demand will start to drop over the coming months.
The use of telehealth surged during the pandemic, and some experts expect it will remain elevated. Treating more patients at home could mean suppliers will have to shift how they get medical products to patients or health care providers.
India is experiencing a surge in COVID-19 cases. The U.S. is sending supplies to help overwhelmed hospitals and speed up vaccine manufacturing.
Many companies sought out supply chain visibility during the pandemic. Now, they’re unlikely to go back.
After problems with the Johnson & Johnson and AstraZeneca vaccines, Europe plots a new course. Also, Johnson & Johnson leaders are optimistic about vaccine despite setbacks.
J&J’s shot makes up a small portion of the vaccine campaign in the U.S., so the impact should be small.
The number of biologic drugs and gene therapies is growing, and logistics companies are increasing their capacity for temperature-controlled transportation to support them.
Drug shortages have plagued the U.S. for years, but the scarcity of certain drugs during the pandemic energized some experts to renew efforts to address the problem.
Armed with more data and real-world examples, some public health officials are renewing their calls to delay second doses
President Joe Biden’s infrastructure plan is light on details, but it could affect the health care supply chain.
Drug manufacturers are trying to massively scale up production, which will require companies to share information and governments to make financial investments.
The pandemic slashed ride volumes for medical transportation providers that brought patients to appointments. Now, some want to bring drugs and supplies to patients.
Criminals are trying to sell fake COVID-19 vaccines to desperate governments and citizens, threatening trust in the real health care supply chain.
